Highlights
- Market Cap
- $1.81B
- Enterprise Value
- $2.10B
- EPS (TTM)
- $1.93
- PE Ratio
- 11.07
- PEG Ratio
- 1.35
- Total Revenue (TTM)
- $1.91B
- Gross Profit (TTM)
- $367.72M
- EBITDA (TTM)
- $227.04M
- Year Range
- $11.84 - $24.99
- Target Price
- $22.00
- ROA (TTM)
- 7.36%
- ROE (TTM)
- 19.10%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in MEDNAX, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
MEDNAX, Inc. (MD) has returned -0.00% so far this year and 47.62% over the past 12 months. Over the last ten years, MD has returned -10.46% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
MEDNAX, Inc.
- 1D
- 2.84%
- 1M
- 7.76%
- YTD
- -0.00%
- 6M
- 27.70%
- 1Y
- 47.62%
- 3Y*
- 12.78%
- 5Y*
- -3.34%
- 10Y*
- -10.46%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Sep 20, 1995, MD's average daily return is +0.07%, while the average monthly return is +1.23%. At this rate, your investment would double in approximately 4.7 years.
Historically, 54% of months were positive and 46% were negative. The best month was Jun 2000 with a return of +69.3%, while the worst month was Feb 1999 at -52.2%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 7 months.
On a daily basis, MD closed higher 51% of trading days. The best single day was Mar 25, 1999 with a return of +70.5%, while the worst single day was Feb 12, 1999 at -47.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.05% | -7.16% | 7.76% | -0.00% | |||||||||
| 2025 | 6.55% | 5.65% | -1.90% | -11.11% | 9.86% | 1.41% | -14.63% | 40.49% | -2.67% | 1.31% | 41.96% | -11.21% | 63.03% |
| 2024 | 0.65% | -2.24% | 9.62% | -11.57% | -17.59% | 3.28% | 10.46% | 30.22% | 6.72% | 6.30% | 21.43% | -12.30% | 41.08% |
| 2023 | 3.30% | 2.54% | -5.27% | -3.89% | -7.19% | 6.84% | -3.38% | 2.91% | -10.05% | -9.83% | -26.88% | 10.98% | -37.42% |
| 2022 | -10.14% | -4.01% | 0.04% | -21.12% | 4.32% | 8.75% | 7.85% | -21.36% | -7.35% | 17.50% | -17.63% | -7.01% | -45.39% |
| 2021 | 11.12% | -10.41% | 4.26% | 3.34% | 21.50% | -5.72% | -3.42% | 10.27% | -11.46% | -4.22% | -9.81% | 10.79% | 10.88% |
Benchmark Metrics
MEDNAX, Inc. has an annualized alpha of 10.38%, beta of 0.76, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 21, 1995.
- This stock participated in 108.15% of S&P 500 Index downside but only 92.51% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 10.38%
- Beta
- 0.76
- R²
- 0.08
- Upside Capture
- 92.51%
- Downside Capture
- 108.15%
Return for Risk
Risk / Return Rank
MD ranks 75 for risk / return — better than 75% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for MEDNAX, Inc. (MD) and compare them to a chosen benchmark (S&P 500 Index).
| MD | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.04 | 0.90 | +0.15 |
Sortino ratioReturn per unit of downside risk | 1.85 | 1.39 | +0.47 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.21 | +0.03 |
Calmar ratioReturn relative to maximum drawdown | 2.16 | 1.40 | +0.76 |
Martin ratioReturn relative to average drawdown | 4.62 | 6.61 | -1.99 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore MD risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the MEDNAX, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the MEDNAX, Inc. was 92.08%, occurring on Jun 11, 2024. The portfolio has not yet recovered.
The current MEDNAX, Inc. drawdown is 74.97%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.08% | Aug 18, 2015 | 2219 | Jun 11, 2024 | — | — | — |
| -89.74% | Feb 1, 1999 | 335 | May 26, 2000 | 966 | Apr 2, 2004 | 1301 |
| -66.06% | Jan 18, 2008 | 214 | Nov 20, 2008 | 614 | May 2, 2011 | 828 |
| -54.33% | May 30, 1996 | 221 | Apr 14, 1997 | 453 | Jan 29, 1999 | 674 |
| -26.52% | Sep 13, 2004 | 27 | Oct 19, 2004 | 135 | May 3, 2005 | 162 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of MEDNAX, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how MEDNAX, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MD, comparing it with other companies in the Medical Care Facilities industry. Currently, MD has a P/E ratio of 11.1. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for MD compared to other companies in the Medical Care Facilities industry. MD currently has a PEG ratio of 1.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MD relative to other companies in the Medical Care Facilities industry. Currently, MD has a P/S ratio of 1.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MD in comparison with other companies in the Medical Care Facilities industry. Currently, MD has a P/B value of 2.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |